Copyright: ©Author(s) 2026.
World J Clin Cases. Jun 6, 2026; 14(16): 119700
Published online Jun 6, 2026. doi: 10.12998/wjcc.v14.i16.119700
Published online Jun 6, 2026. doi: 10.12998/wjcc.v14.i16.119700
Table 1 Characteristics of the included studies
| Ref. | Study design | Follow-up (weeks) | n (total) | Female (%) | Age (years) | BMI | Thyroid-stimulating hormone baseline | Malabsorption | Disease |
| Brancato et al[24], 2014 | Retrospective cohort | 14 | 53 | 94.3 | 45 | 26.8 | 3.04 | 35.9% | Thyroiditis (66%), thyroidectomy (26%), goiter (8%) |
| Negro et al[25], 2014 | Prospective cohort | 54 | 200 | 81 | 53 | - | 1.71 | None | Surgical (29%) or autoimmune (71%) |
| Vita et al[26], 2014 | Prospective cohort | 27 | 24 | 75 | 56.2 | - | 4.1 | 100% | Primary hypothyroidism (58%) or DTC (42%) |
| Cappelli et al[27], 2017 | RCT | 54 | 102 | 78.4 | 49.4 | 24.1 | 0.28 | None | DTC |
| Fallahi et al[28], 2016 | Prospective cohort | 54 | 21 | 81 | 51 | 24.4 | 7.6 | None | Autoimmune thyroiditis (62%), nodular goiter (38%) |
| Lombardi et al[29], 2017 | RCT | 10 | 155 | 84.5 | 51.5 | 26.4 | 8 | None | Benign diseases only |
| Fallahi et al[30], 2018 | Prospective cohort | 15 | 105 | 77 | 48 | 24.5 | 2.55 | None | Thyroid cancer only (papillary/follicular) |
| Baratta et al[31], 2025 | RCT | 10 | 130 | 100 | 51.6 | 26.4 | 8 | None | Thyroidectomized patients |
| Gatta et al[32], 2025 | Retrospective cohort | 13 | 275 | 78.2 | 53 | 25.7 | 1.2 | 27.6% | DTC (28%) vs benign (72%) |
Table 2 Certainty of evidence using the Grades of Recommendation, Assessment, Development and Evaluation approach
| Outcomes | Anticipated absolute effects (95%CI) | n of participants (studies) | Certainty of the evidence (GRADE) | Comments |
| Liquid levothyroxine | ||||
| Thyroid-stimulating hormone | SMD 0.91 lower (1.52 lower to 0.3 lower) | 1115 (9 studies) | Lowa,b | Liquid levothyroxine may lead to a greater reduction in thyroid-stimulating hormone levels compared to tablet levothyroxine, but the evidence is uncertain |
| T4 levels | SMD 0.34 higher (0.15 higher to 0.52 higher) | 480 (5 studies) | Moderatea | Liquid levothyroxine probably results in slightly higher circulating T4 levels compared to tablet levothyroxine |
| T3 levels | SMD 0.25 higher (0.06 higher to 0.44 higher) | 432 (4 studies) | Moderatea | Liquid levothyroxine probably results in slightly higher T3 levels compared to tablet levothyroxine |
- Citation: Farhan M, Patel T, Obais MAHN, Taslimi H, Hanif M, Khalid K, Qaqour A, Waisi J, Khalid H, Abbas Husain AHA, Hammouda R, Khan SU, Patel BD, Sardarova N, Awosika A. Liquid or soft-gel levothyroxine vs tablet levothyroxine in athyreotic adults after total thyroidectomy: Systematic review and meta-analysis. World J Clin Cases 2026; 14(16): 119700
- URL: https://www.wjgnet.com/2307-8960/full/v14/i16/119700.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v14.i16.119700